专栏名称: 肿瘤资讯
分享肿瘤领域最新进展,传播正确肿瘤防治理念,提高全社会对肿瘤的关注!新浪微博:@肿瘤资讯
今天看啥  ›  专栏  ›  肿瘤资讯

JTO社论:奥希替尼联合化疗(FLAURA2方案)应成为所有EGFR敏感突变阳性患者的一线标准治疗方案

肿瘤资讯  · 公众号  · 医学  · 2024-10-24 20:00

文章预览

整理:肿瘤资讯 来源:肿瘤资讯 不要畏惧放弃所拥有而舍弃追求卓越的机会。 Sai-Hong Ignatius Ou Sai-Hong Ignatius Ou Division of Hematology/Oncology, Department of Medicine, UCI School of Medicine; board-certified UCI Health medical oncologist who specializes in the diagnosis and treatment of lung and thyroid cancers; Hamoui Salous Endowed Chair for Thoracic Oncology Research; Editor-in-Chief — Lung Cancer: Targets and Therapy; Associate Editor — Journal of Thoracic Oncology; Assistant Clinical Professor Medicine, School of Medicine (2003-2008); Certified, American Board of Internal Medicine, Hematology (2004); Adjunct Assistant Professor of Epidemiology, School of Medicine (2008-Present); Health Science Associate Clinical Professor Medicine, School of Medicine (2008-Present); Best Doctors in America (Medical Oncology and Hematology 2011-2013); Member of the American Society of Clinical Oncology (ASCO) Metastatic Non-Small Cell Lung Cancer Tracking Sci ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览